All News about Catalent Inc
![](https://mms.businesswire.com/media/20240828983391/en/772236/22/Catalent_CMYK.jpg)
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
August 29, 2024
From Catalent, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/786826/gettyimages-1088326366.jpg)
![](https://mms.businesswire.com/media/20240716141571/en/2186807/22/006-11%2B12.07.24-CATALENT-Schorndorf.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Beyond The Numbers: 6 Analysts Discuss Catalent Stock
April 04, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
(CTLT) - Analyzing Catalent's Short Interest
February 28, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
In-Depth Examination Of 5 Analyst Recommendations For Catalent
February 20, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/05/Stock-HealthCloud-01-adobe.jpg)
![](https://mms.businesswire.com/media/20240529233385/en/772236/22/Catalent_CMYK.jpg)
From Catalent, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/778632/individual-investor-devices-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/24/Hedge-Funds-Photo-by-Panchenko-Vladimir-.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/05/ctlt1600.png)
![](https://mms.businesswire.com/media/20240507163487/en/772236/22/Catalent_CMYK.jpg)
From Catalent, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/05/02/Ozempic-and-other-drugs-for-weight-loss.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240417817414/en/805853/22/Robbins_LLP.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Wegovy_11.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
![](https://g.foolcdn.com/editorial/images/770468/ozempic.jpg)
Via Talk Markets
![](https://g.foolcdn.com/editorial/images/769494/medicine-pills-fda-approval-stamp.jpg)
![](https://investorplace.com/wp-content/uploads/2022/08/pharmaceutical1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Ozempic-maker-Novo-Nordisk_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240307376172/en/772236/22/Catalent_CMYK.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_7.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/767512/statistic_id271464_diabetics-prevalence-worldwide-2021-2030-and-2045.png)
![](https://cdn.benzinga.com/files/images/story/2024/SP500.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Wall-Street_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/weight-loss-shutter2.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240216824700/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240215083237_sp-500s-surge-to-new-highs-bull-trap-hiding-in-pla.jpg)
S&P 500's surge to new highs: Bull trap hiding in plain sight?
February 15, 2024
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.